Ledger.Open graph →
SEC Form D · filed July 10, 2020

Scopus BioPharma Inc

Offering
$636K
Sold
$636K
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
New York, NY
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Joshua R. Lamstein · New York, NYExec · DirectorAshish P. Sanghrajka · New York, NYExec · DirectorRobert J. Gibson · New York, NYExec · DirectorIra S. Greenspan · New York, NYDirectorPaul J. Hopper · New York, NYExec · DirectorTwin Grove Capital LLC · Dover, DEDirectorMaxim Medvedev · Moscow, 1ZExec · DirectorDarshan D. Vyas · Orange, CAExec · DirectorJohn Kretchmer · Seattle, WAExec · DirectorKristi Shafer · Seattle, WAExec · DirectorMark Leavitt · New York, NYExec · DirectorWalter Marting · Virginia City, NVExec · DirectorNull Groveport General Manager Limited · St. Peter Port, Y7DirectorCynthia J. Moreland · Goleta, CAExec · DirectorAdam Bernstein · Washington, Washington, D.C.Exec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗